Trade

Rossari Biotech share price

Moderate risk
  • 24%Low risk
  • 24%Moderate risk
  • 24%Balanced risk
  • 24%High risk
  • 24%Extreme risk
  • 536.40(-0.67%)
    January 16, 2026 13:25:42 PM IST
    • NSE
    • BSE
  • Vol : 20.17 K (NSE + BSE)
    Last 20 day avg : 27.53 K

Rossari Biotech is trading -0.67% lower at Rs 536.40 as compared to its last closing price. Rossari Biotech has been trading in the price range of 542.90 & 535.00. Rossari Biotech has given -7.27% in this year & -5.47% in the last 5 days. Rossari Biotech has TTM P/E ratio 25.05 as compared to the sector P/E of 24.21.There are 4 analysts who have initiated coverage on Rossari Biotech. There are 2 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 36.88 Crores in its last quarter.Listed peers of Rossari Biotech include Pidilite Industries (-0.95%), Solar Industries India (-0.75%), SRF (0.20%).The Mutual Fund holding in Rossari Biotech was at 13.47% in 31 Dec 2025. The MF holding has increased from the last quarter. The FII holding in Rossari Biotech was at 2.32% in 31 Dec 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jan 16, 2026, 08:01 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.27
    High volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.18
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.09
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    1.88
    Indicates Fair Valuation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
Price range
Day Range
Lowest
535.00
Highest
542.90
52 week range
Lowest
537.80
Highest
839.80
Rossari Biotech Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Pidilite Industries
Bearish
1,480.60-0.951,50,210.4670.1715.090.692.26
Solar Industries India
Bearish
12,787.60-0.751,15,715.0690.2625.760.089.52
SRF
Neutral
3,036.000.2090,049.5673.187.270.2516.14
Asian Paints
Neutral
2,776.90-1.372,66,359.6368.0113.770.907.13
Coromandel International
Bullish
2,321.00-68,382.9939.156.370.505.40
Mutual Fund Ownership
View all
Motilal Oswal Small Cap Fund Regular Growth
NA
  • Amount Invested (Cr.) 62.22
  • % of AUM 1.26
UTI Small Cap Fund Regular Growth
2/5
  • Amount Invested (Cr.) 39.65
  • % of AUM 0.88
Canara Robeco Small Cap Fund Regular Growth
2/5
  • Amount Invested (Cr.) 70.85
  • % of AUM 0.57
UTI Flexi Cap Fund Regular Plan Growth
2/5
  • Amount Invested (Cr.) 115.96
  • % of AUM 0.46
SBI Small Cap Fund Regular Plan Growth
3/5
  • Amount Invested (Cr.) 133.84
  • % of AUM 0.39
Rossari Biotech Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-01-17Quarterly Results
2025-10-15Quarterly Results
2025-07-19Quarterly Results
2025-04-25Audited Results & Final Dividend
2025-01-21Quarterly Results
About the company Rossari Biotech
  • IndustryChemical Manufacturing
  • ISININE02A801020
  • BSE Code543213
  • NSE CodeROSSARI
Rossari Biotech Limited is an India-based company. The Company is engaged in the manufacturing, selling and distribution of specialty chemicals. Its products cater to global brands in the Fast Moving Consumer Goods (FMCG) sector and find applications in a host of consumer centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products. It operates through three segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals (TSC), and Animal Health and Nutrition (AHN). The HPPC produces acrylic polymers. The TSC provides solutions for pre-treatment, dyeing and printing, finishing, and specialty chemicals for the textile industry. The AHN provides wellness solutions for pet animals and poultry, focusing on their health and performance. Its products include DETPRO 2040 CP, Rossblue, Amido Silicones, Rosselectro C, NEOBIND 7050 SC LIQUID, and others. Its flagship brand is Freshee.
  • Management Info
  • Edward MenezesExecutive Chairman of the Board, Co-Founder
  • Sunil ChariManaging Director, Co-Founder, Executive Director
  • Ketan SablokGroup Chief Financial Officer
  • Parul GuptaHead- Company Secretary & Legal
Rossari Biotech Share Price FAQs

Rossari Biotech is trading at 536.40 as on Fri Jan 16 2026 07:55:42. This is -0.67% lower as compared to its previous closing price of 540.00.

The market capitalization of Rossari Biotech is 2965.71 Cr as on Fri Jan 16 2026 07:55:42.

The average broker rating on Rossari Biotech is Strong Buy. The breakup of analyst rating is given below -

  • 2 analysts have given a strong buy rating
  • 2 analysts have given a buy rating
  • 0.00 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Rossari Biotech is 839.80 whereas the 52 wk low is 537.80

Rossari Biotech can be analyzed on the following key metrics -

  • TTM P/E: 25.05
  • Sector P/E: 24.21
  • Dividend Yield: 0.09%
  • D/E ratio: 0.28

Rossari Biotech reported a net profit of 136.38 Cr in 2025.

The Mutual Fund Shareholding was 13.47% at the end of 31 Dec 2025.